• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis.

作者信息

Liao Shu-Yi, Gerber Anthony N, Zelarney Pearlanne, Make Barry, Wechsler Michael E

机构信息

Department of Medicine, National Jewish Health, Denver, CO.

Department of Medicine, National Jewish Health, Denver, CO.

出版信息

Chest. 2022 Jun;161(6):1490-1493. doi: 10.1016/j.chest.2021.12.654. Epub 2022 Jan 10.

DOI:10.1016/j.chest.2021.12.654
PMID:35016912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8743857/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84a9/8743857/2bcef6e2dc61/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84a9/8743857/2bcef6e2dc61/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84a9/8743857/2bcef6e2dc61/gr1_lrg.jpg

相似文献

1
Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis.慢性疾病中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）mRNA疫苗抗体反应受损：一项真实世界分析
Chest. 2022 Jun;161(6):1490-1493. doi: 10.1016/j.chest.2021.12.654. Epub 2022 Jan 10.
2
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病患者对单剂SARS-CoV-2 mRNA疫苗的抗体反应。
Ann Rheum Dis. 2021 Aug;80(8):1098-1099. doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23.
3
SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis.接受生物治疗的哮喘患者对SARS-CoV-2 mRNA疫苗的抗体反应：一项真实世界分析
Am J Respir Crit Care Med. 2022 Sep 1;206(5):644-648. doi: 10.1164/rccm.202203-0599LE.
4
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.辉瑞-BioNTech 新冠疫苗接种 6 个月后针对 SARS-CoV-2 关注变异株的抗体反应
Microbiol Spectr. 2022 Apr 27;10(2):e0225221. doi: 10.1128/spectrum.02252-21. Epub 2022 Mar 9.
5
Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis.针对多发性硬化症患者的 SARS-CoV-2 灭活疫苗和 mRNA 疫苗的安全性和体液免疫应答率。
Mult Scler Relat Disord. 2022 Mar;59:103690. doi: 10.1016/j.msard.2022.103690. Epub 2022 Feb 13.
6
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
7
Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.BNT162b2 mRNA COVID-19 疫苗的抗体反应动力学：7 个月随访研究。
Medicina (Kaunas). 2021 Dec 5;57(12):1330. doi: 10.3390/medicina57121330.
8
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.实体器官移植受者完成mRNA SARS-CoV-2疫苗接种后体液免疫反应不佳。
Clin Chem. 2021 Dec 30;68(1):251-253. doi: 10.1093/clinchem/hvab149.
9
Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.肾移植受者中mRNA-1273和BNT162b2新冠病毒mRNA疫苗免疫原性的比较
Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.
10
Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?对常规抗病毒疫苗的抗体反应不理想的个体能否从 SARS-CoV-2 mRNA 疫苗接种中获得足够的抗体？
Viruses. 2022 May 3;14(5):956. doi: 10.3390/v14050956.

引用本文的文献

1
Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients.对接种新冠疫苗的特发性肺纤维化患者免疫活性的综合分析。
Front Immunol. 2025 Jan 8;15:1436491. doi: 10.3389/fimmu.2024.1436491. eCollection 2024.
2
Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults with Underlying Medical Conditions in the United States.二价（原始毒株/奥密克戎BA.4/BA.5）mRNA新冠疫苗mRNA-1273.222与BNT162b2二价疫苗在美国有基础疾病成年人中的比较效果
Vaccines (Basel). 2024 Sep 27;12(10):1107. doi: 10.3390/vaccines12101107.
3

本文引用的文献

1
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study.免疫抑制对SARS-CoV-2 mRNA疫苗免疫原性的影响：一项前瞻性队列研究。
Ann Intern Med. 2021 Nov;174(11):1572-1585. doi: 10.7326/M21-1757. Epub 2021 Aug 31.
2
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.新冠疫苗突破性感染在已接种疫苗的医护人员中发生。
N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28.
3
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.
Association between antibody responses post-vaccination and severe COVID-19 outcomes in Scotland.
苏格兰接种疫苗后抗体反应与严重新冠病毒疾病结局之间的关联
NPJ Vaccines. 2024 Jun 14;9(1):107. doi: 10.1038/s41541-024-00898-w.
4
The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus.疫苗接种在 COPD 中的作用：流感、SARS-CoV-2、肺炎球菌、百日咳、呼吸道合胞病毒和水痘带状疱疹病毒。
Eur Respir Rev. 2023 Sep 6;32(169). doi: 10.1183/16000617.0034-2023. Print 2023 Sep 30.
5
Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients.慢性肺病患者中，疫苗引发的针对新冠病毒的B细胞和T细胞免疫功能受损。
ERJ Open Res. 2023 Oct 16;9(5). doi: 10.1183/23120541.00400-2023. eCollection 2023 Sep.
6
Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients.慢性肺病患者对新冠病毒的疫苗诱导B细胞和T细胞免疫受损。
medRxiv. 2023 Jan 28:2023.01.25.23284971. doi: 10.1101/2023.01.25.23284971.
7
Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study.接受 BNT162b2 SARS-CoV-2 疫苗接种的间质性肺疾病患者的体液反应：一项前瞻性队列研究。
Respir Res. 2022 Sep 1;23(1):226. doi: 10.1186/s12931-022-02155-x.
8
Antibody Response to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in COPD: A Cohort Study.慢性阻塞性肺疾病患者对严重急性呼吸综合征冠状病毒2疫苗接种的抗体反应：一项队列研究
Chronic Obstr Pulm Dis. 2022 Oct 26;9(4):591-595. doi: 10.15326/jcopdf.2022.0315.
9
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.8 个月内单次给予 casirivimab 和 imdevimab 预防 COVID-19 的疗效和安全性：一项随机、双盲、安慰剂对照试验。
Lancet Infect Dis. 2022 Oct;22(10):1444-1454. doi: 10.1016/S1473-3099(22)00416-9. Epub 2022 Jul 5.
10
SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis.接受生物治疗的哮喘患者对SARS-CoV-2 mRNA疫苗的抗体反应：一项真实世界分析
Am J Respir Crit Care Med. 2022 Sep 1;206(5):644-648. doi: 10.1164/rccm.202203-0599LE.
风湿性和肌肉骨骼疾病患者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗的高抗体反应。
Ann Rheum Dis. 2021 Oct;80(10):1351-1352. doi: 10.1136/annrheumdis-2021-220656. Epub 2021 May 24.
4
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
5
Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases.利妥昔单抗而非其他抗风湿疗法，与风湿性疾病患者对SARS-CoV-2疫苗的血清学反应受损有关。
Ann Rheum Dis. 2021 Oct;80(10):1357-1359. doi: 10.1136/annrheumdis-2021-220604. Epub 2021 May 11.
6
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
7
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.SARS-CoV-2 的持久免疫控制和预防再感染的前景。
Nat Rev Immunol. 2021 Jun;21(6):395-404. doi: 10.1038/s41577-021-00550-x. Epub 2021 Apr 29.
8
COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis.慢性阻塞性肺疾病与新冠病毒病不良结局风险：一项系统评价与荟萃分析
EClinicalMedicine. 2021 Mar;33:100789. doi: 10.1016/j.eclinm.2021.100789. Epub 2021 Mar 18.
9
Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases.吸入性和全身性皮质类固醇的使用与慢性肺部疾病患者 2019 年冠状病毒病（COVID-19）检测阳性的相关性。
Respir Med. 2021 Jan;176:106275. doi: 10.1016/j.rmed.2020.106275. Epub 2020 Nov 28.
10
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.五种市售血清学检测方法检测 SARS-CoV-2 抗体的性能比较及识别高中和抗体滴度个体。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02257-20.